Hidekazu Tanaka
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Aims Heart failure (HF) hospitalizations are associated with poor survival outcomes, emphasizing the need for early intervention. Deep learning algorithms have shown promise in HF detection through electrocardiogram (ECG). However, their utility in ongoing HF monitoring remains uncertain. This study developed a deep learning model using 12-lead ECGs collected at 2 different time points to evaluate HF status changes, aiming to enhance early intervention and continuous monitoring in various healthcare settings. Methods and results We analysed 30 171 ECGs from 6531 adult patients at Kobe University Hospital. The participants were randomly assigned to training, validation, and test datasets. A Transformer-based model was developed to classify HF status into deteriorated, improved, and no-change classes based on ECG waveform signals at two different time points. Performance metrics, such as the area under the receiver operating characteristic curve (AUROC) and accuracy, were calculated, and attention mapping via gradient-weighted class activation mapping was utilized to interpret the model’s decision-making ability. The patients had an average age of 64.6 years (±15.4 years) and brain natriuretic peptide of 66.3 pg/mL (24.6–175.1 pg/mL). For HF status classification, the model achieved an AUROC of 0.889 [95% confidence interval (CI): 0.879–0.898] and an accuracy of 0.871 (95% CI: 0.864–0.878). Conclusion Transformer-based deep learning model demonstrated high accuracy in detecting HF status changes, highlighting its potential as a non-invasive, efficient tool for HF monitoring. The reliance of the model on ECGs reduces the need for invasive, costly diagnostics, aligning with clinical needs for accessible HF management. IRB Information Kobe University Hospital Clinical & Translational Research Center (reference number: B220208)
Year:
2025
Left atrial (LA) enlargement frequently occurs in atrial fibrillation (AF) patients, and this enlargement is associated with the development of heart failure, thromboembolism, or atrial functional mitral regurgitation (AFMR). AF patients can develop LA enlargement over time, but its progression depends on the individual. So far, the factors that cause progressive LA enlargement in AF patients have thus not been elucidated, so that the aim of this study was to identify the factors associated with the progression of LA enlargement in AF patients. We studied 100 patients with persistent or permanent AF (aged: 67 ± 2 years, 40 females). Echocardiography was performed at baseline and 12 (5–30) months after follow‐up. LA size was evaluated as the LA volume index which was calculated with the biplane modified Simpson's method from apical four‐and two‐chamber views, and then normalized to the body surface area (LAVI). The deterioration of AFMR after follow‐up was defined as a deterioration in severity of mitral regurgitation (MR) by a grade of 1 or more. Multivariate regression analysis demonstrated that hypertension ( p = .03) was an independently associated parameter of progressive LA enlargement, as was baseline LAVI. In addition, the Kaplan–Meier curve indicated that patients with hypertension tended to show greater deterioration of AFMR after follow‐up than those without hypertension (log‐rank p = .08). Hypertension proved to be strongly associated with progression of LA enlargement over time in patients with AF. Our findings provide new insights for better management of patients with AF to prevent the development of AFMR.
Year:
2023
Collaborators (1)
Ken-ichi Hirata
Kobe University Graduate School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.